Henk Portengen
- Oncology top 2%
- Molecular Biology top 5%
- Cancer Research top 1%
- Genetics top 2%
- Pulmonary and Respiratory Medicine top 10%
- Co-authors
- John A. FoekensMaxime P. LookIris L. van StaverenJan G.M. KlijnJ.G.M. KlijnWim L.J. van PuttenMarion E. Meijer‐van GelderJ. Alexieva-Figusch
- Topics
- HER2/EGFR in Cancer Research (14 papers)Estrogen and related hormone effects (13 papers)Growth Hormone and Insulin-like Growth Factors (6 papers)
- Partner nations
- NetherlandsGermanyItaly
In The Last Decade
Henk Portengen
40 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 97
- Oncology 1.5k
- Molecular Biology 1.5k
- Cancer Research 1.2k
- Genetics 808
- Pulmonary and Respiratory Medicine 305
Countries citing papers authored by Henk Portengen
This map shows the geographic impact of Henk Portengen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henk Portengen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henk Portengen more than expected).
Fields of papers citing papers by Henk Portengen
This network shows the impact of papers produced by Henk Portengen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henk Portengen. The network helps show where Henk Portengen may publish in the future.
Co-authorship network of co-authors of Henk Portengen
This figure shows the co-authorship network connecting the top 25 collaborators of Henk Portengen. A scholar is included among the top collaborators of Henk Portengen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henk Portengen. Henk Portengen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 38 | |
| 2 | 85 | |
| 3 | 102 | |
| 4 | 71 | |
| 5 | 264 | |
| 6 | 12 | |
| 7 | 50 | |
| 8 | 7 | |
| 9 | 138 | |
| 10 | 143 | |
| 11 | 47 | |
| 12 | 101 | |
| 13 | 13 | |
| 14 | 41 | |
| 15 | 97 | |
| 16 | 73 | |
| 17 | 70 | |
| 18 | 89 | |
| 19 | 3 | |
| 20 | 1 |
About Henk Portengen
Henk Portengen is a scholar working on Cancer Research, Oncology and Genetics, having authored 40 papers that have together received 3.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (14 papers), Estrogen and related hormone effects (13 papers) and Growth Hormone and Insulin-like Growth Factors (6 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.5k citations) and Immunology and Allergy (249 citations). Henk Portengen has collaborated with scholars based in Netherlands, Germany and Italy. Frequent co-authors include John A. Foekens, Maxime P. Look, Iris L. van Staveren, Jan G.M. Klijn, J.G.M. Klijn, Wim L.J. van Putten, Marion E. Meijer‐van Gelder, J. Alexieva-Figusch, W L van Putten and Harry A. Peters. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.